CK-2127107 amplifies skeletal muscle response to nerve activation in humans-Reference-Cited by-同舟云学术

CK-2127107 amplifies skeletal muscle response to nerve activation in humans

Published:2017-12-11 Issue:5 Volume:57 Page:729-734
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Andrews Jinsy A.¹,Miller Timothy M.¹,Vijayakumar Vipin¹,Stoltz Randall²,James Joyce K.¹,Meng Lisa¹,Wolff Andrew A.¹,Malik Fady I.¹

Affiliation:

1. Cytokinetics, Inc., 280 East Grand Avenue; South San Francisco California 94080 USA

2. Covance, Inc.; Evansville Indiana USA

Funder

Cytokinetics

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Reference18 articles.

1. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease;Monani;Neuron,2005

2. Central fatigue during isometric exercise in amyotrophic lateral sclerosis;Kent-Braun;Muscle Nerve,2000

3. Respiratory muscle strength as a predictive biomarker for survival in amyotrophic lateral sclerosis;Polkey;Am J Respir Crit Care Med,2017

4. Specially adapted housing eligibility for amyotrophic lateral sclerosis beneficiaries. Interim final rule;Department of Veterans Affairs;Fed Regist,2013

5. Tinetti and Berg balance scales correlate with disability in hereditary peripheral neuropathies: a preliminary study;Monti Bragadin;Eur J Phys Rehabil Med,2015

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of human metabolites of fast skeletal troponin activators Tirasemtiv and Reldesemtiv for doping control purposes;Drug Testing and Analysis;2024-08-13

2. Tirasemtiv enhances submaximal muscle tension in an Acta1:p.Asp286Gly mouse model of nemaline myopathy;Journal of General Physiology;2024-02-20

3. Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2023-08-29

4. Spinal Muscular Atrophy: An Overview;OBM Genetics;2023-06-14

5. COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2023-05-30